Pursuant to Regulation 30 read with Schedule III of SEBI (LODR) Regulations, 2015, this is to inform you that the Board of Directors of the Company at its meeting held today, i.e Tuesday, ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Wardwizard Healthcare's board approved its audited standalone financial results for Q4 and FY ended March 31, 2025, with a clean (unmodified) audit opinion from Mahesh Udhwani & Associates. Revenue from operations jumped sharply to ₹41.7 lakh in FY25 from ₹11.1 lakh in FY24, as the company began healthcare services from July 2024. However, expenses surged to ₹324.3 lakh, driving the net loss to ₹271.3 lakh (vs ₹44.9 lakh loss last year). The board also appointed Upadhyay & Company LLP as internal auditor for FY26. A separate filing confirmed the company is not classified as a 'Large Corporate' under SEBI's framework.
Negative for shareholders — despite revenue tripling, the company's losses widened nearly six-fold and its net worth turned deeply negative (₹311 lakh), with borrowings exceeding ₹970 lakh and negative operating cashflows, signalling serious financial stress and a need for further funding despite the new healthcare venture ramping up.